OSR Holdings Retires $2.02M Warrants with $1.06M Premium Conversion Note
OSR Holdings retired $2.02 million of outstanding warrants by converting them into a $1.06 million convertible promissory note to optimize its capital structure. The note carries a $1.00 per share conversion price—100% premium to the prior $0.49 closing price—and includes a six-month conversion restriction to stabilize trading and support NASDAQ compliance.
1. Transaction Overview
OSR Holdings retired $2.02 million of outstanding warrants by consolidating them into a convertible promissory note with a total face value of $1,055,555, including $555,555 in cash proceeds to bolster near-term liquidity.
2. Convertible Note Terms
The note features a fixed $1.00 per share conversion price—approximately a 100% premium to the $0.49 closing price on April 8, 2026—and is subject to a six-month conversion restriction to prevent immediate dilution.
3. Strategic Rationale
By removing a significant warrant overhang at a discount to prior value, OSR Holdings streamlines its capital structure, strengthens its equity story and aligns investor interests around long-term shareholder value.
4. Implications for Shareholders
The transaction reduces potential dilution, supports share price stability under NASDAQ’s minimum bid requirements, and secures capital to advance the company’s immunotherapy, regenerative biologics and medtech initiatives.